You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 3, March 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmological Disorders, Other
 •Ophthalmology, Other
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Genomic Promise

Personalized Medicine for Ophthalmology

Janey L. Wiggs, MD, PhD

Arch Ophthalmol. 2008;126(3):422-423.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The advances in genetics and genomics during the past decade have provided insight into the molecular processes underlying many ophthalmic disorders. These discoveries are valuable to the scientific community but also to physicians, as newly revealed genetic information is increasingly used to improve the quality of health care. Ideally, patient care should include comprehensive screening with predictive tests and appropriate and timely preventive and preemptive therapies. Genetic factors have been shown to contribute to disease development and response to therapy. Because each patient has a unique genetic background and a specific set of disease-associated factors, health care approaches should be personalized regarding screening for risk factors, establishing a diagnosis, and predicting response to therapy. Although comprehensive evaluations for all ocular diseases are not yet possible, considerable progress has been made and ongoing applications of human genome information to important clinical problems in ophthalmology will lead . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Biobanks and the importance of detailed phenotyping: a case study--the European Glaucoma Society GlaucoGENE project
Founti et al.
Br J Ophthalmol 2009;93:577-581.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.